Fosun Group Shrugs Off Brexit Worry, Will seek more Opportunities in UK and Europe
Girish Shetti | | Jun 29, 2016 08:34 AM EDT |
(Photo : Getty Images.) Fosun Group Chairman Guo Guangchang has shrugged off worries over Brexit, claiming that Brexit will bring more investment opportunities in UK and Europe.
Fosun Group, a Chinese international conglomerate and private investment company, will be seeking more investment opportunities in the United Kingdom and European markets, despite the ongoing volatility due to Britain's decision to leave the European Union, a move often shortened as Brexit.
Shrugging off worries regarding Brexit, Guo Guangchang, chairman of Fosun Group, claimed that it will actually pave way for more investment opportunities for investors in European markets.
Like Us on Facebook
"For a value investor, volatility is a friend not an enemy. Market volatility and panic will probably bring better investment opportunities. So we are increasingly looking for development opportunities in Europe, and particularly in the UK," Guo said.
Guo asserted that his company, which has made substantial investment in U.K and Europe, has barely been affected by Brexit vote. He stressed on investment opportunities in oil and commodities. "Oil is not trading at a high price, and Fosun has accumulated experience and learned lessons. So we will increase our investment in oil."
However, market analysts say that while Fosun will continue to expand through strategic investments, the company will also have to make efforts to reduce its mounting debt. Fosun's net debt rose by a fifth to 115 billion yuan ($17.3 billion) in the previous year. Many industry experts have voiced concern over Fosun's increasing debt, claiming that it might force the company to curb its global ambition.
Some reports indicate that mounting debt has made Fosun Group far more conservative on the acquisition front this year. Fosun has reportedly made fewer acquisitions this year than last year. Last month, the company was in the news for acquiring Indian pharmaceutical company Gland Pharma.
TagsFosun Group International, Guo Guangchang, brexit, china
©2015 Chinatopix All rights reserved. Do not reproduce without permission
EDITOR'S PICKS
-
Did the Trump administration just announce plans for a trade war with ‘hostile’ China and Russia?
-
US Senate passes Taiwan travel bill slammed by China
-
As Yan Sihong’s family grieves, here are other Chinese students who went missing abroad. Some have never been found
-
Beijing blasts Western critics who ‘smear China’ with the term sharp power
-
China Envoy Seeks to Defuse Tensions With U.S. as a Trade War Brews
-
Singapore's Deputy PM Provides Bitcoin Vote of Confidence Amid China's Blanket Bans
-
China warns investors over risks in overseas virtual currency trading
-
Chinese government most trustworthy: survey
-
Kashima Antlers On Course For Back-To-Back Titles
MOST POPULAR
LATEST NEWS
Zhou Yongkang: China's Former Security Chief Sentenced to Life in Prison
China's former Chief of the Ministry of Public Security, Zhou Yongkang, has been given a life sentence after he was found guilty of abusing his office, bribery and deliberately ... Full Article
TRENDING STORY
-
China Pork Prices Expected to Stabilize As The Supplies Recover
-
Elephone P9000 Smartphone is now on Sale on Amazon India
-
There's a Big Chance Cliffhangers Won't Still Be Resolved When Grey's Anatomy Season 13 Returns
-
Supreme Court Ruled on Samsung vs Apple Dispute for Patent Infringement
-
Microsoft Surface Pro 5 Rumors and Release Date: What is the Latest?